Table S5 Sample Clauses
Table S5. Age-adjusted Incidence Rates and Incidence Rate Ratios of Serous Carcinoma by Race/Ethnicity for 2004–2009 (Period 1) and 2010–2015 (Period 2) N IR (95% CI) IRR (95% CI) P value Overall Overall Overall Total NHW NHB NHO Hispanic 2004-2009* 2010-2015 2004-2009* 2010-2015 2004-2009* 2010-2015 2004-2009* 2010-2015 2004-2009* 2010-2015 removed
Table S5. Selection of the reference model for the sooty albatross. Capture (p), transitions (ø) and survival (F) may be constant (.), time (t) or state (s) dependent and np is the number of parameters of the model. The best model is in italics.
Table S5. Regression results for resting state connectome similarity when all covariates are included except for child age (for multicollinearity reasons, N = 76 dyads). Unstandardized B (SE) Standardized β p F df p R2 3.32 7, 68 .004 .26 Maltreatment -.087 (.036) -.243 .016 Parent Age -.001 (.001) -.124 .332 Age Difference -.006 (.002) -.363 .008 Child Sex .000 (.017) -.001 .995 Parent Sex -.011 (.019) -.070 .540 Different Sex .003 (.017) .020 .848 SES .019 (.013) .184 .146
Table S5. The different calculation models of integrated anammox or denitrification activity in the Beili agricultural upland soil.
Table S5. Relative risk (RR) estimates and 95% confidence interval (CI) for ED visits due to acute renal failure (ARF) associated with one day passed in the duration of heat wave. Heat waves are defined as periods of ≥ 2 consecutive days with temperature (T) or apparent temperature (AT) exceeding the 98th percentile using daily maximum (MAX), minimum (MIN), or average (AVG). The first day of the heat wave period is excluded ARF Day Sample size Lag0 R.R. (95%C.I.) Lag1 R.R. (95%C.I.) Lag2 R.R. (95%C.I.) Lag3 R.R. (95%C.I.) MAXT 2 29 1.00 (0.87, 1.15) 1.06 (0.92, 1.21) 1.07 (0.94, 1.22) 1.14 (1.00, 1.30) MAXT 3 18 1.05 (0.86, 1.29) 1.09 (0.89, 1.33) 1.22 (1.01, 1.48) 1.03 (0.84, 1.26) MAXT 4 10 1.00 (0.80, 1.26) 1.18 (0.95, 1.47) 1.13 (0.90, 1.41) 0.85 (0.66, 1.09) MAXT >4 34 1.14 (0.96, 1.34) 1.04 (0.88, 1.23) 1.06 (0.89, 1.27) 0.96 (0.80, 1.14) MINT 2 64 1.05 (0.97, 1.15) 1.07 (0.98, 1.16) 1.01 (0.93, 1.10) 1.08 (1.00, 1.18) MINT 3 44 1.06 (0.95, 1.18) 1.02 (0.92, 1.14) 1.09 (0.98, 1.21) 1.06 (0.95, 1.18) MINT 4 29 1.08 (0.95, 1.23) 1.15 (1.02, 1.30) 1.06 (0.94, 1.20) 1.03 (0.90, 1.17) MINT >4 95 1.08 (0.99, 1.19) 1.06 (0.97, 1.16) 1.00 (0.92, 1.10) 0.98 (0.90, 1.07) AVGT 2 35 1.03 (0.92, 1.15) 1.08 (0.97, 1.20) 1.01 (0.90, 1.13) 1.05 (0.94, 1.18) AVGT 3 22 1.10 (0.95, 1.28) 1.02 (0.88, 1.19) 0.98 (0.84, 1.15) 1.04 (0.89, 1.21) AVGT 4 14 1.04 (0.85, 1.28) 1.08 (0.89, 1.32) 1.06 (0.87, 1.30) 1.03 (0.83, 1.27) AVGT >4 52 1.13 (0.98, 1.03) 1.08 (0.94, 1.25) 1.05 (0.90, 1.21) 0.92 (0.79, 1.06) MAXAT 2 37 1.05 (0.94, 1.18) 1.03 (0.91, 1.16) 1.16 (1.03, 1.30) 1.03 (0.92, 1.16) MAXAT 3 24 1.06 (0.90, 1.24) 1.29 (1.12, 1.49) 1.08 (0.93, 1.26) 0.87 (0.74, 1.03) MAXAT 4 15 1.28 (1.08, 1.51) 1.14 (0.96, 1.34) 0.91 (0.75, 1.10) 1.07 (0.89, 1.27) MAXAT >4 33 1.11 (0.93, 1.31) 1.01 (0.85, 1.22) 0.99 (0.83, 1.18) 0.82 (0.68, 0.98) MINAT 2 35 1.03 (0.91, 1.16) 1.16 (1.03, 1.3) 1.04 (0.93, 1.18) 1.09 (0.97, 1.23) MINAT 3 21 1.14 (0.99, 1.32) 1.17 (1.02, 1.35) 1.06 (0.92, 1.24) 0.95 (0.80, 1.11) MINAT 4 13 1.24 (1.05, 1.48) 1.2 (1.00, 1.43) 0.96 (0.79, 1.17) 1.19 (0.99, 1.43) MINAT >4 27 1.10 (0.94, 1.27) 1.15 (0.99, 1.33) 1.13 (0.98, 1.30) 1.01 (0.87, 1.17) AVGAT 2 36 1.00 (0.89, 1.13) 1.16 (1.04, 1.30) 1.13 (1.01, 1.26) 1.01 (0.90, 1.13) AVGAT 3 22 1.08 (0.94, 1.23) 1.26 (1.12, 1.43) 1.05 (0.92, 1.20) 0.97 (0.83, 1.12) AVGAT 4 15 1.25 (1.09, 1.45) 1.12 (0.96, 1.30) 1.03 (0.87, 1.21) 0.99 (0.84, 1.17) AVGAT >4 45 1.13 (0.99, 1.29) 1.08 (0.93, 1.24) 1.01 (0.88, 1.16) 0.89 (0.77, 1.02...
